Benjamin Edwards’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $19.2M | Buy |
128,930
+3,405
| +3% | +$478K | 0.17% | 154 |
|
|
2026
Q2 | $15.9M | Sell |
125,525
-6,539
| -5% | -$862K | 0.14% | 170 |
|
|
2026
Q1 | $18.4M | Sell |
132,064
-3,145
| -2% | -$440K | 0.18% | 144 |
|
|
2025
Q4 | $16.6M | Sell |
135,209
-33,468
| -20% | -$4.07M | 0.18% | 134 |
|
|
2025
Q3 | $18.7M | Buy |
168,677
+3,796
| +2% | +$431K | 0.21% | 119 |
|
|
2025
Q2 | $18.3M | Sell |
164,881
-10,054
| -6% | -$1.07M | 0.23% | 107 |
|
|
2025
Q1 | $19.6M | Sell |
174,935
-1,234
| -0.7% | -$127K | 0.27% | 98 |
|
|
2024
Q4 | $16.3M | Sell |
176,169
-189,651
| -52% | -$17.1M | 0.23% | 110 |
|
|
2024
Q3 | $30.7M | Buy |
365,820
+347,895
| +1,941% | +$26.5M | 0.45% | 61 |
|
|
2024
Q2 | $1.23M | Buy |
17,925
+125
| +0.7% | +$8.34K | 0.24% | 115 |
|
|
2024
Q1 | $1.3M | Sell |
17,800
-562
| -3% | -$43.2K | 0.26% | 102 |
|
|
2023
Q4 | $1.49M | Sell |
18,362
-3,735
| -17% | -$291K | 0.32% | 89 |
|
|
2023
Q3 | $1.66M | Sell |
22,097
-607
| -3% | -$46.7K | 0.39% | 73 |
|
|
2023
Q2 | $1.75M | Sell |
22,704
-4,218
| -16% | -$336K | 0.41% | 71 |
|
|
2023
Q1 | $2.23M | Buy |
26,922
+1,001
| +4% | +$82.9K | 0.55% | 52 |
|
|
2022
Q4 | $2.22M | Buy |
25,921
+788
| +3% | +$62.4K | 0.59% | 47 |
|
|
2022
Q3 | $1.55M | Sell |
25,133
-142
| -0.6% | -$8.95K | 0.47% | 64 |
|
|
2022
Q2 | $1.56M | Buy |
25,275
+3,153
| +14% | +$195K | 0.46% | 59 |
|
|
2022
Q1 | $1.32M | Buy |
22,122
+4,621
| +26% | +$295K | 0.38% | 78 |
|
|
2021
Q4 | $1.27M | Buy |
17,501
+1,475
| +9% | +$102K | 0.41% | 70 |
|
|
2021
Q3 | $1.12M | Buy |
16,026
+834
| +5% | +$58.6K | 0.68% | 41 |
|
|
2021
Q2 | $1.05M | Sell |
15,192
-145
| -0.9% | -$9.7K | 0.72% | 45 |
|
|
2021
Q1 | $991K | Buy |
15,337
+153
| +1% | +$9.9K | 0.75% | 44 |
|
|
2020
Q4 | $885K | Buy |
15,184
+4,961
| +49% | +$299K | 0.69% | 51 |
|
|
2020
Q3 | $646K | Sell |
10,223
-249
| -2% | -$17.3K | 0.53% | 68 |
|
|
2020
Q2 | $806K | Buy |
10,472
+2,156
| +26% | +$165K | 0.67% | 53 |
|
|
2020
Q1 | $622K | Buy |
8,316
+6,032
| +264% | +$417K | 0.65% | 52 |
|
|
2019
Q4 | $148K | Buy |
2,284
+4
| +0.2% | +$260 | 0.3% | 76 |
|
|
2019
Q3 | $145K | Buy |
2,280
+110
| +5% | +$7.19K | 0.31% | 69 |
|
|
2019
Q2 | $147K | Buy |
2,170
+288
| +15% | +$18.9K | 0.36% | 57 |
|
|
2019
Q1 | $122K | Buy |
+1,882
| New | +$125K | 0.58% | 37 |
|
Other funds holding GILD
Benjamin Edwards's GILD Position: Q3 2026 in Review
Benjamin Edwards increased its Gilead Sciences (GILD) stake by 2.7% in Q3 2026, buying an estimated $478K and bringing the position to 128,930 shares worth $19.2M. The position accounts for 0.17% of the portfolio, ranked #154.
Benjamin Edwards first reported a position in GILD in Q1 2019 and has held it in 31 quarters since. The position peaked at $30.7M in Q3 2024. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Benjamin Edwards held 128,930 shares of Gilead Sciences worth $19.2M as of Q3 2026.
- Benjamin Edwards bought 3,405 Gilead Sciences shares in Q3 2026, an estimated $478K.
- Gilead Sciences made up 0.17% of Benjamin Edwards's portfolio in Q3 2026, its #154 holding.
- Benjamin Edwards first reported a position in Gilead Sciences in Q1 2019 and has held it in 31 quarters since.
- Benjamin Edwards's Gilead Sciences position peaked at $30.7M in Q3 2024.
- 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.